Hip response to romosozumab in glucocorticoid users: beyond systemic bone turnover markers.
- DOI
- 10.1007/s00198-026-08114-2
- Published
- 2026 Jun 22
- Container
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00198-026-08114-2,
title = {Hip response to romosozumab in glucocorticoid users: beyond systemic bone turnover markers.},
author = {Zhang K and Zhao M and Li D},
year = {2026},
journal = {Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA},
doi = {10.1007/s00198-026-08114-2},
url = {https://doi.org/10.1007/s00198-026-08114-2}
}RIS
TY - JOUR TI - Hip response to romosozumab in glucocorticoid users: beyond systemic bone turnover markers. AU - Zhang K AU - Zhao M AU - Li D PY - 2026 JO - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA DO - 10.1007/s00198-026-08114-2 UR - https://doi.org/10.1007/s00198-026-08114-2 ER -
APA
K, Z., M, Z., & D, L. (2026). Hip response to romosozumab in glucocorticoid users: beyond systemic bone turnover markers.. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. https://doi.org/10.1007/s00198-026-08114-2
Source records
- pubmed · retrieved 2026-09-26T03:50:15.084Z
- europe-pmc · retrieved 2026-09-26T03:50:15.106Z